Trending Stock News

Gamco Investors Et Al Trimmed Its Freeport Mcmoran Copper&Gold C (FCX) Holding as Stock Price Declined; Brandes Investment Partners LP Holding in Taro Pharmaceutical Inds LTD (TARO) Increased as Market Value Declined

Freeport-McMoRan Inc. (NYSE:FCX) Logo

Brandes Investment Partners Lp increased its stake in Taro Pharmaceutical Inds Ltd (TARO) by 225.9% based on its latest 2017Q4 regulatory filing with the SEC. Brandes Investment Partners Lp bought 49,327 shares as the company’s stock declined 8.04% with the market. The institutional investor held 71,163 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $7.45M, up from 21,836 at the end of the previous reported quarter. Brandes Investment Partners Lp who had been investing in Taro Pharmaceutical Inds Ltd for a number of months, seems to be bullish on the $4.62 billion market cap company. The stock decreased 1.48% or $1.73 during the last trading session, reaching $115.14. About 96,348 shares traded or 19.41% up from the average. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) has declined 17.38% since May 25, 2017 and is downtrending. It has underperformed by 28.93% the S&P500.

Mario Gabelli decreased its stake in Freeport Mcmoran Copper&Gold C (FCX) by 18.59% based on its latest 2017Q4 regulatory filing with the SEC. Gamco Investors Inc Et Al sold 862,300 shares as the company’s stock declined 4.75% with the market. The hedge fund run by Mario Gabelli held 3.78M shares of the basic industries company at the end of 2017Q4, valued at $71.58M, down from 4.64 million at the end of the previous reported quarter. Gamco Investors Inc Et Al who had been investing in Freeport Mcmoran Copper&Gold C for a number of months, seems to be less bullish one the $25.18B market cap company. The stock increased 0.17% or $0.03 during the last trading session, reaching $17.38. About 13.01 million shares traded. Freeport-McMoRan Inc. (NYSE:FCX) has risen 41.20% since May 25, 2017 and is uptrending. It has outperformed by 29.65% the S&P500.

Since January 31, 2018, it had 0 buys, and 1 sale for $419,125 activity.

More notable recent Freeport-McMoRan Inc. (NYSE:FCX) news were published by: Seekingalpha.com which released: “Freeport-McMoRan Will Rebound” on May 03, 2018, also Fool.com with their article: “Freeport-McMoRan Stock Upgraded: What You Need to Know” published on May 23, 2018, Forbes.com published: “What Factors Have Led To Freeport’s Recent Stock Slump?” on May 18, 2018. More interesting news about Freeport-McMoRan Inc. (NYSE:FCX) were released by: Seekingalpha.com and their article: “Freeport-McMoRan: Indonesian-Related Sell-Off” published on May 01, 2018 as well as Bizjournals.com‘s news article titled: “Top of the pay grade: Here are the highest-paid CEOs in Phoenix” with publication date: May 25, 2018.

Analysts await Freeport-McMoRan Inc. (NYSE:FCX) to report earnings on July, 24. They expect $0.59 EPS, up 247.06% or $0.42 from last year’s $0.17 per share. FCX’s profit will be $854.79M for 7.36 P/E if the $0.59 EPS becomes a reality. After $0.46 actual EPS reported by Freeport-McMoRan Inc. for the previous quarter, Wall Street now forecasts 28.26% EPS growth.

Among 24 analysts covering Freeport-McMoran Copper & Gold (NYSE:FCX), 6 have Buy rating, 5 Sell and 13 Hold. Therefore 25% are positive. Freeport-McMoran Copper & Gold had 108 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Monday, April 9 by Jefferies. The stock has “Hold” rating by S&P Research on Tuesday, September 1. The stock of Freeport-McMoRan Inc. (NYSE:FCX) earned “Hold” rating by Macquarie Research on Thursday, September 7. The company was maintained on Monday, August 31 by Deutsche Bank. The firm has “Market Perform” rating given on Wednesday, July 26 by BMO Capital Markets. The stock has “Sector Perform” rating by RBC Capital Markets on Tuesday, October 27. RBC Capital Markets maintained Freeport-McMoRan Inc. (NYSE:FCX) rating on Sunday, July 30. RBC Capital Markets has “Hold” rating and $1400 target. Stifel Nicolaus maintained Freeport-McMoRan Inc. (NYSE:FCX) on Tuesday, February 6 with “Hold” rating. On Tuesday, August 29 the stock rating was maintained by Stifel Nicolaus with “Hold”. The firm has “Neutral” rating given on Thursday, September 14 by FBR Capital.

Investors sentiment decreased to 0.92 in Q4 2017. Its down 0.08, from 1 in 2017Q3. It turned negative, as 77 investors sold FCX shares while 205 reduced holdings. 78 funds opened positions while 182 raised stakes. 989.88 million shares or 2.99% more from 961.13 million shares in 2017Q3 were reported. L & S Inc reported 0.26% in Freeport-McMoRan Inc. (NYSE:FCX). Federated Invsts Pa owns 220,578 shares. Reilly Financial Advsrs Ltd Liability has 0.01% invested in Freeport-McMoRan Inc. (NYSE:FCX). Blackrock invested in 0.08% or 89.10 million shares. Carroll Assocs accumulated 1,613 shares. Pub Employees Retirement Association Of Colorado holds 253,296 shares or 0.03% of its portfolio. Plante Moran Advsrs Ltd reported 20,690 shares or 0.22% of all its holdings. Alliancebernstein Limited Partnership invested in 0.04% or 2.65 million shares. Jefferies Group Limited Liability, New York-based fund reported 22,904 shares. Factory Mutual Insurance owns 200,000 shares for 0.04% of their portfolio. The Massachusetts-based Fmr Ltd Liability has invested 0.06% in Freeport-McMoRan Inc. (NYSE:FCX). Rockefeller Financial stated it has 36 shares or 0% of all its holdings. Wesbanco National Bank & Trust holds 17,615 shares. Gotham Asset Management Ltd Liability Co has invested 0.15% in Freeport-McMoRan Inc. (NYSE:FCX). Bnp Paribas Asset Management Hldgs accumulated 28,448 shares or 0% of the stock.

Gamco Investors Inc Et Al, which manages about $15.96B US Long portfolio, upped its stake in Tejon Ranch Co Del Com (NYSE:TRC) by 128,760 shares to 627,960 shares, valued at $13.04M in 2017Q4, according to the filing. It also increased its holding in Loral Space & Communicatns Ico (NASDAQ:LORL) by 49,721 shares in the quarter, for a total of 740,209 shares, and has risen its stake in Liberty Braves Group A.

Brandes Investment Partners Lp, which manages about $26.91B and $4.95B US Long portfolio, decreased its stake in Johnson & Johnson (NYSE:JNJ) by 3,464 shares to 55,046 shares, valued at $7.69 million in 2017Q4, according to the filing. It also reduced its holding in Pfizer Inc (NYSE:PFE) by 114,388 shares in the quarter, leaving it with 3.71M shares, and cut its stake in Mitsubishi Ufj Finl Group In (NYSE:MTU).

Among 2 analysts covering Taro Pharm (NYSE:TARO), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Taro Pharm had 5 analyst reports since May 23, 2017 according to SRatingsIntel. The rating was maintained by H.C. Wainwright on Monday, April 2 with “Buy”. On Tuesday, May 15 the stock rating was maintained by H.C. Wainwright with “Buy”. The firm has “Neutral” rating by Credit Suisse given on Tuesday, May 23. The stock has “Buy” rating by H.C. Wainwright on Tuesday, May 22.

More notable recent Taro Pharmaceutical Industries Ltd. (NYSE:TARO) news were published by: Benzinga.com which released: “Earnings Scheduled For May 17, 2018” on May 17, 2018, also Seekingalpha.com with their article: “More on Taro Pharmaceutical Q4 results” published on May 18, 2018, Businesswire.com published: “Taro Provides Results for Year Ended March 31, 2018” on May 17, 2018. More interesting news about Taro Pharmaceutical Industries Ltd. (NYSE:TARO) were released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: ASCO Abstracts, Fibrocell, Ispen And More” published on May 17, 2018 as well as Investingnews.com‘s news article titled: “Crescita’s US Prescription Product is “Launching Shortly,” says CEO” with publication date: May 23, 2018.

Freeport-McMoRan Inc. (NYSE:FCX) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *